During the past two and a half decades, factors such as physical inactivity, insulin resistance, increased plasma levels of IL-6, increased intramuscular fat storage, and adequacy of protein consumption have been identified as “therapeutic targets” in combating sarcopenia during the aging process [87,88]. The gene discussed is IL6; the disease is Insulin resistance.